MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Let’s Talk Medtech

Behind the Design and Engineering of a Breakthrough Device for Stroke Rehab

Leaders from Neurolutions guest star on this episode of Let's Talk Medtech to talk about the design and engineering behind the recently authorized IpsiHand System for use in chronic stroke patients to facilitate muscle re-education through its brain-computer interface platform.

Image courtesy of Neurolutionsmedical device design

As MD+DI reported last month, FDA recently authorized the IpsiHand System, pictured above. 

The IpsiHand is a breakthrough device for patients 18 and older undergoing stroke rehabilitation to facilitate muscle re-education, and for maintaining or increasing range of motion. The Neurolutions IpsiHand Upper Extremity Rehabilitation System is a brain-computer interface device designed to assist in rehabilitation for stroke patients with upper extremity (hand, wrist, and arm) disability.

Neurolutions CEO Leo Petrossian, PhD, and Eric C. Leuthardt, MD, the company's co-founder and chief scientific officer, joined us for this episode of Let's Talk Medtech to share some insight into the design and engineering considerations for the device, as well as some lessons learned regarding FDA's breakthrough device designation pathway. Click the player below to listen to the conversation.

For more information about the IpsiHand System, visit the Neurolutions' website.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.